Key Events This Week
23 Feb: Shares hit lower circuit amid heavy selling pressure
27 Feb: Stock surged to upper circuit on strong buying interest
Weekly Close: Rs.111.00, down 5.37% vs Sensex -0.96%
Mar 30
BSE+NSE Vol: 19.5 k

At Rs 99.00, sellers were still queuing — but there were no buyers willing to take the other side. Lotus Eye Hospital & Institute Ltd locked at its lower circuit of 3.62% on 30 Mar 2026, with unfilled sell orders and a frozen price.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of its performance and prospects.
Read full news article
Shares of Lotus Eye Hospital & Institute Ltd surged to hit the upper circuit limit on 16 Mar 2026, reflecting robust buying interest and a significant daily price gain. The stock outperformed its sector and benchmark indices despite a micro-cap status and a recent downgrade in its mojo grade, signalling renewed investor enthusiasm in the hospital sector.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article
23 Feb: Shares hit lower circuit amid heavy selling pressure
27 Feb: Stock surged to upper circuit on strong buying interest
Weekly Close: Rs.111.00, down 5.37% vs Sensex -0.96%

Shares of Lotus Eye Hospital & Institute Ltd surged to hit the upper circuit limit on 27 Feb 2026, propelled by robust buying interest and a significant intraday gain. The stock outperformed its sector and broader market indices, reflecting renewed investor confidence despite subdued delivery volumes and a micro-cap market capitalisation of ₹225 crores.
Read full news article
Shares of Lotus Eye Hospital & Institute Ltd plunged to their lower circuit limit on 23 Feb 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹112.88, down 3.94% on the day, marking a continuation of a sharp three-day decline that has wiped out over 13% of its value. This sudden drop underscores growing concerns about the company’s near-term prospects amid subdued investor participation and unfilled supply in the market.
Read full news articleClosure of Trading Window
Please refer attachment
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2026 inter alia to consider and approve the proposal for voluntary delisting of the Companys equity shares from NSE
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available